Anita Garlind

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study

Yvonne Freund‐Levi, Maria Eriksdotter, Tommy Cederholm et al. · Archives of Neurology · 2006 · 746 citations

Medicine, Nutritional Sciences, Pharmacology +17

Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms

Yvonne Freund‐Levi, Hans Basun, Tommy Cederholm et al. · International Journal of Geriatric Psychiatry · 2007 · 185 citations

Medicine, Nutrition, Nutritional Sciences +17

Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study

Inger Vedin, Tommy Cederholm, Yvonne Freund‐Levi et al. · American Journal of Clinical Nutrition · 2008 · 172 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +16

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

Taher Darreh‐Shori, Ove Almkvist, Zhenpeng Guan et al. · Neurology · 2002 · 155 citations

Medicine, Neurology, Pharmacology +15

The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense

Ello Karelson, Nenad Bogdanović, Anita Garlind et al. · Neurochemical Research · 2001 · 115 citations

Life Sciences, Neurobiology, Neuroscience +17